The magnitude of agonist-induced Ca 2؉ sensitization of force is tissue-dependent, but an explanation for this diversity is unknown. Ca 2؉ sensitization is thought to involve a G-protein-mediated inhibition of myosin light chain phosphatase activity by phosphorylation of the myosin-targeting subunit (MYPT). The MYPT has two isoforms that differ by a central insert, which lies near this phosphorylation site. Expression of MYPT isoforms is both developmentally regulated and tissue-specific. We hypothesized that the presence or absence of the central insert determines the magnitude of agonist-induced Ca 2؉ sensitization. Throughout development, the chicken aorta exclusively expresses the splice-in MYPT isoform, and guanosine 5-O-(thiotriphosphate) (GTP␥S) produces a significant force enhancement. Early during development, the chicken gizzard expresses the splice-in MYPT isoform, and GTP␥S produced a Ca 2؉ sensitization. In the gizzard coincident with the shift in expression from the splice-in to splice-out MYPT isoform, GTP␥S no longer produced force enhancement. In addition, adenosine 5-O-(thiotriphosphate) (ATP␥S) phosphorylated only adult gizzard tissue, the only tissue that did not demonstrate a Ca 2؉ sensitization. These results suggest that the relative expression of splice-in/ splice-out MYPT isoforms determines the magnitude of agonist-induced force enhancement and that MYPT phosphorylation is not required for Ca 2؉ sensitization.The importance of Ca 2ϩ -calmodulin-dependent myosin light chain kinase (MLCK) 1 for smooth muscle activation has been well described (1). However, recent evidence suggests that regulation of MLC phosphatase activity is physiologically important for force regulation in smooth muscle (reviewed in Refs. 2-6). This regulation of MLC phosphatase activity can produce a Ca 2ϩ sensitization, or an increase in force at a constant [Ca 2ϩ ], and a Ca 2ϩ desensitization, or a reduction in force at a constant [Ca 2ϩ ]. Agonist stimulation produces a Ca 2ϩ sensitization of the contractile filaments (7). The mechanism for the agonist-induced Ca 2ϩ sensitization, or force enhancement, is thought to depend on a G-protein-mediated inhibition of MLC phosphatase activity resulting in an increase in MLC 20 phosphorylation (8). The MLC phosphatase is a trimeric protein consisting of a 38-kDa catalytic subunit, a 20-kDa subunit of unknown function, and a large (110 -133 kDa) myosin-targeting subunit (MYPT) (reviewed in Ref. 3)). G-protein-induced inhibition of MLC phosphatase activity has been suggested to be regulated by phosphorylation of the MYPT (9), possibly by either Rhokinase (10, 11) or Zip-like kinase (12). However, direct activation of the G-proteins (8), as well as agonist stimulation (7), does not produce the same magnitude of force enhancement in all smooth muscle tissues, and the mechanism to explain this diversity has yet to be elucidated.The MYPT has two isoforms that are produced by alternative splicing of a central exon (13). The alternatively spliced segment lies near a phosphoryl...